Spica Therapeutics is a pioneering biotech company dedicated to transforming macrophage biology into breakthrough therapies for patients across multiple therapeutic areas. Leveraging its proprietary functional macrophage fingerprinting technology, Spica identifies and selectively targets disease-relevant macrophage sub
Investors 1
| Date | Name | Website |
| 15.02.2025 | Bioqube Ve... | bioqubeven... |
Mentions in press and media 1
| Date | Title | Description |
| 22.01.2025 | Bioqube Ventures Unveils Spica Therapeutics to Pioneer Macrophage-Subset Targeted Therapies | Brussels, Belgium, January 9, 2025 – Spica Therapeutics (“Spica”), a pioneering biotech company focused on macrophage biology, today announced its emergence from stealth mode, supported by Bioqube Ventures. Headquartered in Belgium, with a ... |